Skip to main content
SpringerLink
Log in

Clinical and genetic risk factors for venous thromboembolism in Chinese population

  • Review
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, carries significant mortality and morbidity. The most important and effective way to reduce VTE incidence is to identify the patients at risk and give necessary prevention. VTE is a multifactorial and complicated disorder. Major risk factors for VTE include surgery and trauma, acute medical illness, active cancer and pregnancy. Genetic factors increase susceptibility to the disease and are useful in predicting the development of VTE. Gene-gene and gene-environment interactions alter and magnify the clinical picture in this disorder. This brief review summarizes some selected clinical and genetic risk factors for VTE based on the current research in China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Heit J A. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol, 2008, 28(3): 370–372

    Article  CAS  PubMed  Google Scholar 

  2. Silverstein M D, Heit J A, Mohr D N, Petterson TM, O’Fallon W M, Melton L J III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med, 1998, 158: 585–593

    Article  CAS  PubMed  Google Scholar 

  3. Cohen A T, Agnelli G, Anderson F A, Arcelus J I, Bergqvist D, Brecht J G, Greer I A, Heit J A, Hutchinson J L, Kakkar A K, Mottier D, Oger E, Samama M M, Spannagl M. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost, 2007, 98(4): 756–764

    CAS  PubMed  Google Scholar 

  4. Cheng T O. Medicine in modern China. J Am Geriatr Soc, 1973, 21: 289–313

    CAS  PubMed  Google Scholar 

  5. Cheng T O. Increasing incidence of pulmonary embolism in China: another price of modernization. Int J Cardiol, 2007, 120(2): 143–144

    Article  PubMed  Google Scholar 

  6. Tan X Y, He J G, Zou Z P, Zhao Y F, Chen B P, Gao Y, Xiong CM, Ni X H, Cheng X S. Changes of the proportion and mortality of pulmonary thromboembolism in hospitalized patients from 1974 to 2005. Chin Med J (Engl), 2006, 119(12): 998–1002

    Google Scholar 

  7. Cai B, Xu L, Guo S. Trends of underline diseases of pulmonary embolism from Peking Union Medical College Hospital. Zhonghua Jie He He Hu Xi Za Zhi, 2001, 24(12): 715–717 (in Chinese)

    CAS  PubMed  Google Scholar 

  8. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol, 2007, 44(2): 62–69

    Article  PubMed  Google Scholar 

  9. Greer I A. Inherited thrombophilia and venous thromboembolism. Best Pract Res Clin Obstet Gynaecol, 2003, 17(3): 413–425

    Article  PubMed  Google Scholar 

  10. Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, Di Minno G. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest, 2000, 118(5): 1405–1411

    Article  CAS  PubMed  Google Scholar 

  11. Douketis J D, Moinuddin I. Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach. Pol Arch Med Wewn, 2008, 118(4): 209–215

    PubMed  Google Scholar 

  12. Prandoni P, Samama M M. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients. Br J Haematol, 2008, 141(5): 587–597

    Article  CAS  PubMed  Google Scholar 

  13. Sun K K, Wang C, Guli X T, Luo Q. Risk factors and clinical features of deep venous thrombosis: a report of 388 cases. Zhonghua Jie He He Hu Xi Za Zhi, 2004, 27(11): 727–730 (in Chinese)

    PubMed  Google Scholar 

  14. Li X L, Lu W J, Yu N S, Lu Y H, Lin Z Q, Dong W Q. Prophylaxis for deep vein thrombosis with low molecular heparin following hip and knee surgery. Zhongguo Xiufu Chongjian Waike Zazhi, 2001, 15 (1): 39–41 (in Chinese)

    CAS  PubMed  Google Scholar 

  15. Guan Z P, Lü H S, Chen Y Z, Song Y N, Qin X L, Jiang J. Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty. Zhonghua Wai Ke Za Zhi, 2005, 43(20): 1317–1320 (in Chinese)

    PubMed  Google Scholar 

  16. Ko P S, Chan W F, Siu T H, Khoo J, Wu W C, Lam J J. Deep venous thrombosis after total hip or knee arthroplasty in a “low-risk” Chinese population. J Arthroplasty, 2003, 18(2): 174–179

    Article  CAS  PubMed  Google Scholar 

  17. Lee F Y, Chu W, Chan R, Leung Y F, Liu K H, Ng S M, Lai P B, Metreweli C, Lau W Y. Incidence of deep vein thrombosis after colorectal surgery in a Chinese population. ANZ J Surg, 2001, 71(11): 637–640

    Article  CAS  PubMed  Google Scholar 

  18. Sun K K, Wang C, Pang B S, Yang Y H, He W, Chen T F, Zhao Q H, Zhang J. Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients. Zhonghua Liu Xing Bing Xue Za Zhi, 2004, 25(12): 1019–1023 (in Chinese)

    PubMed  Google Scholar 

  19. Sun K K, Wang C, Pang B S, Yang Y H. The prevalence of deep venous thrombosis in hospitalized patients with stroke. Zhonghua Yi Xue Za Zhi, 2004, 84(8): 637–641 (in Chinese)

    PubMed  Google Scholar 

  20. Xu X F, Yang Y H, Zhai Z G, Liu S, Zhu G F, Li C S, Wang C. Prevalence and incidence of deep venous thrombosis among patients in medical intensive care unit. Zhonghua Liu Xing Bing Xue Za Zhi, 2008, 29(10): 1034–1037 (in Chinese)

    PubMed  Google Scholar 

  21. Joynt G M, Li T S, Griffith J F, Gomersall C D, Yap F H, Ho A M, Leung P. The incidence of deep venous thrombosis in Chinese medical intensive care unit patients. Hong Kong Med J, 2009, 15(1): 24–30

    PubMed  Google Scholar 

  22. Chan L Y, Yuen P M, Lo W K, Lau T K. Symptomatic venous thromboembolism in Chinese patients after gynecologic surgery: incidence and disease pattern. Acta Obstet Gynecol Scand, 2002, 81(4): 343–346

    PubMed  Google Scholar 

  23. Egeberg O. Thrombophlia caused by inherited deficiency of blood antithrombin. Scand J Clin Lab Invest, 1965, 17: 92

    Article  CAS  PubMed  Google Scholar 

  24. Simioni P, Scudeller A, Girolami A. Factor V Leiden and thrombophilia. N Engl J Med, 1995, 332(20): 1382

    CAS  PubMed  Google Scholar 

  25. Reitsma P H. Genetic heterogeneity in hereditary thrombophilia. Haemostasis, 2000, 30(Suppl 2): 1–10

    CAS  PubMed  Google Scholar 

  26. Murin S, Marelich G P, Arroliga A C, Matthay R A. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med, 1998, 158(5 Pt 1): 1369–1373

    CAS  PubMed  Google Scholar 

  27. Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996, 88(10): 3698–3703

    CAS  PubMed  Google Scholar 

  28. Zhai Z, Wang C, Yang Y H, Pang B S, Xiao B, Liu Y M, Mao Y L, Weng X Z. The relationship between polymorphisms of prothrombin G20210 and pulmonary thromboembolism in Chinese Han population. Shoudu Yike Daxue Xuebao, 2006, (1): 1–5 (in Chinese)

  29. Jun Z J, Ping T, Lei Y, Li L, Ming S Y, Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol, 2006, 28(2): 111–116

    Article  CAS  PubMed  Google Scholar 

  30. Chan D K, Hu G, Tao H, Owens D, Vun C M, Woo J, Chong B H. A comparison of polymorphism in the 3’-untranslated region of the prothrombin gene between Chinese and Caucasians in Australia. Br J Haematol, 2000, 111(4): 1253–1255

    Article  CAS  PubMed  Google Scholar 

  31. Zhai Z G, Wang C, Yang Y H, Pang B S, Xiao B, Liu Y M, Mao Y L. Study on the relationship between polymorphisms of susceptible genes in coagulation pathway related to pulmonary thromboembolism in Chinese Han population. Zhonghua Liu Xing Bing Xue Za Zhi, 2006, 27(2): 165–169 (in Chinese)

    CAS  PubMed  Google Scholar 

  32. Zhai Z G, Wang C, Yang Y H, Pang B S, Xiao B, Liu Y M, Mao Y L, Weng X Z. Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population. Zhonghua Yi Xue Za Zhi, 2006, 86(19): 1313–1317 (in Chinese)

    CAS  PubMed  Google Scholar 

  33. Han XM, Ren J F, Hao B, Cao W D, Liu X E, Hou L H, Guo Z P, Yu B, Wang X F, Ding Q L, Yang L H. Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2007, 15(3): 612–616 (in Chinese)

    CAS  PubMed  Google Scholar 

  34. Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res, 2002, 106(1): 7–12

    Article  CAS  PubMed  Google Scholar 

  35. Lu Y, Hui R, Zhao Y. Insertion/deletion polymorphsim of the angiotensin I converting enzyme gene and pulmonary thromboembolism in Chinese population. Zhonghua Jie He He Hu Xi Za Zhi, 2001, 24(5): 265–268 (in Chinese)

    CAS  PubMed  Google Scholar 

  36. Le Flem L, Mennen L, Aubry M L, Aiach M, Scarabin P Y, Emmerich J, Alhenc-Gelas M. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol, 2001, 21(3): 445–451

    CAS  PubMed  Google Scholar 

  37. Uitte de Willige S, Van Marion V, Rosendaal F R, Vos H L, de Visser M C, Bertina R M. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost, 2004, 2(8): 1305–1310

    Article  CAS  PubMed  Google Scholar 

  38. Zhai Z, Yin Y, Yang Y, Wang J, Wang C, Xi W. The association between thrombomodulin gene variations and thromboembolic pulmonary hypertension. Am J Respir Crit Care Med, 2009, 179: A3339

    Google Scholar 

  39. Nelson S M, Greer I A. Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. Obstet Gynecol Clin North Am, 2006, 33(3): 413–427

    Article  PubMed  Google Scholar 

  40. Martinelli I, Taioli E, Battaglioli T, Podda G M, Passamonti S M, Pedotti P, Mannucci PM. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med, 2003, 163(22): 2771–2774

    Article  PubMed  Google Scholar 

  41. Pang B S, Wang C, Zhai Z G, Yang Y H, Mao Y L, Huang X X, Zhu J. Changes of blood coagulative and fibrinolytic systems and functions of pulmonary vascular endothelium in patients with pulmonary thromboembolism. Zhonghua Jie He He Hu Xi Za Zhi, 2005, 28(10): 714–716 (in Chinese)

    PubMed  Google Scholar 

  42. Pang B S,Wang C, Lu Y, Yang Y H, Xing G H, Mao Y L, Huang X X, Zhai Z G. Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi, 2007, 87(43): 3074–3078 (in Chinese)

    CAS  PubMed  Google Scholar 

  43. Yin Y D, Wang C, Zhai Z G, Pang B S, Yang Y H, Huang X X. Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism. J Thromb Thrombolysis, 2009, 27(3): 274–279

    Article  CAS  PubMed  Google Scholar 

  44. Hong M, Zhang X, Hu Y, Wang H, He W, Mei H, Yu J, Guo T, Song S. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS. Thromb Res, 2009, 123(3): 556–564

    Article  CAS  PubMed  Google Scholar 

  45. Yang G, Lu H, Gao J, Kou B, Yuan Y, Xu B. Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty. Zhonghua Wai Ke Za Zhi, 2000, 38(1): 25–27 (in Chinese)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China

    Chen Wang & Zhen-Guo Zhai

  2. Baylor College of Medicine, Houston, TX, 77004, USA

    Ying H. Shen

  3. Department of Experimental Medicine and Toxicology, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK

    Lan Zhao

Authors
  1. Chen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen-Guo Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying H. Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chen Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, C., Zhai, ZG., Shen, Y.H. et al. Clinical and genetic risk factors for venous thromboembolism in Chinese population. Front. Med. China 4, 29–35 (2010). https://doi.org/10.1007/s11684-010-0012-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-010-0012-y

Keywords

Search

Navigation